Oncopeptides AB (publ) (ONPPF) News Today → A.I. is a Tidal Wave - Here’s What to Buy (From Chaikin Analytics) (Ad) Free ONPPF Stock Alerts $0.60 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartStock AnalysisAnalyst ForecastsChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOncopeptides AB (publ) - Special Call Transcriptgurufocus.com - March 6 at 9:00 AMOncopeptides AB (publ) To Present Updated Ocean Results Call Transcriptgurufocus.com - March 6 at 9:00 AMOncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bankprnewswire.com - November 25 at 1:11 PMOncopeptides' Pepaxti has been granted marketing authorization in the UKfinance.yahoo.com - November 11 at 2:59 PMOncopeptides announces the market potential for Pepaxti in Europefinance.yahoo.com - November 9 at 11:40 AMOncopeptides publishes Q3 report 2022finance.yahoo.com - November 9 at 11:40 AMOncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufenfinance.yahoo.com - October 26 at 7:29 AMIssue and re-purchase of class C shares for shareholder program and incentive programfinance.yahoo.com - October 20 at 5:38 PMOncopeptides AB: Oncopeptides starts commercialization of Pepaxti in Europe - Germany first marketfinanznachrichten.de - October 5 at 3:44 PMOncopeptides starts commercialization of Pepaxti in Europe - Germany first marketfinance.yahoo.com - October 3 at 10:36 AMSwedish Biotech’s Cancer Drug Fails With FDA Advisersfinance.yahoo.com - September 23 at 10:56 AMOncopeptides provides an update from the meeting with FDAs advisory committee ODACfinance.yahoo.com - September 23 at 10:56 AMBulletin from an Extra Ordinary General meeting in Oncopeptides AB (publ)finance.yahoo.com - September 23 at 10:56 AMBriefing Book for ODAC meeting on benefit/risk profile of Pepaxto now publishedfinance.yahoo.com - September 20 at 5:08 PMONCO.ST - Oncopeptides AB | Stock Price & Latest News | Reutersreuters.com - September 19 at 7:47 PMOncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myelomafinance.yahoo.com - September 7 at 11:53 AMEuropean Commission approves Oncopeptides' Pepaxti for the treatment of patients with relapsed refractory multiple myelomafinance.yahoo.com - August 18 at 9:23 AMOncopeptides AB GAAP EPS of -SEK0.79, revenue of SEK8.8Mseekingalpha.com - August 13 at 11:17 PMOncopeptides publishes Q2 report 2022finance.yahoo.com - August 11 at 6:55 AMOncopeptides publishes year-end report 2021finance.yahoo.com - February 17 at 11:07 AMInvitation to presentation of 2021 year-end resultsfinance.yahoo.com - February 14 at 4:35 PMOncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this timefinance.yahoo.com - January 21 at 8:09 PMOncopeptides phase 3 OCEAN study published in the Lancet Haematologyfinance.yahoo.com - January 13 at 7:24 AMOncopeptides announces year-end cash 2021prnewswire.com - January 5 at 3:17 AMOncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASHfinance.yahoo.com - December 10 at 10:39 AMOncopeptides publishes Q3 2021 reportfinance.yahoo.com - November 24 at 8:51 AMInvitation to presentation of the Q3 2021 resultsfinance.yahoo.com - November 19 at 10:14 AMJakob Lindberg appointed CEO of Oncopeptidesfinance.yahoo.com - November 15 at 10:18 AMOncopeptides has announced the Nomination Committeefinance.yahoo.com - November 12 at 8:11 AMOncopeptides focuses clinical development efforts to increase cash runwayfinance.yahoo.com - November 4 at 1:17 PMOncopeptides appoints Annika Muskantor as interim CFOfinance.yahoo.com - November 1 at 2:04 PMSweden’s Oncopeptides Nosedives After U.S. Treatment Withdrawalfinance.yahoo.com - October 25 at 7:44 AMOncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&Dfinance.yahoo.com - October 22 at 12:24 PMOncopeptides' CFO Anders Martin-Löf will leave the companyfinance.yahoo.com - October 15 at 3:02 PMOncopeptides presents phase 3 OCEAN study results at the IMW meetingprnewswire.com - September 11 at 8:57 AMInvitation to webcast for presentation of OCEAN data presented at IMWfinance.yahoo.com - September 9 at 3:36 PMOncopeptides publishes report for Q2 2021finance.yahoo.com - August 19 at 2:45 AMOncopeptides' PEPAXTO® Receives a Permanent J-Code, Clarifying Reimbursement Processes in Hospital Outpatient and Physician Office Settings of Carefinance.yahoo.com - August 16 at 3:47 PMInvitation to presentation of the Q2 2021 resultsfinance.yahoo.com - August 12 at 5:44 PMRegulatory update from US Food and Drug Administrationprnewswire.com - July 28 at 11:41 AM Get Oncopeptides AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address POTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos. Click here now to see my urgent election warning. ONPPF Media Mentions By Week ONPPF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONPPF News Sentiment▼0.000.34▲Average Medical News Sentiment ONPPF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONPPF Articles This Week▼00▲ONPPF Articles Average Week Get Oncopeptides AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:ONPPF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncopeptides AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
